Comments
Loading...

Tarsus Pharmaceuticals

TARSNASDAQ
Logo brought to you by Benzinga Data
$52.91
0.911.75%
At close: -
$52.91
0.000500.00%
After Hours: 4:01 PM EDT

Tarsus Pharmaceuticals (NASDAQ:TARS) Stock, Earnings Estimates, EPS, And Revenue

Tarsus Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 25
EPS Estimate
$-0.950
Quarterly Revenue Estimate
$49.7M
Annual Revenue
(as of Sep 30)
$129.6M

Analyze the earnings history of Tarsus Pharmaceuticals using advanced sorting and filters.

Data brought to you by Benzinga APIs

Tarsus Pharmaceuticals (TARS) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-13$-0.61$-0.9435.1 %
Jun 20242024-08-08$-0.88$-0.935.38 %
Mar 20242024-05-08$-1.01$-1.2015.8 %
Dec 20232024-02-27$-1.31$-1.363.68 %

Tarsus Pharmaceuticals (TARS) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Sep 20242024-11-13$48.12M$43.44M10.8 %
Jun 20242024-08-08$40.81M$31.71M28.7 %
Mar 20242024-05-08$27.61M$17.83M54.9 %
Dec 20232024-02-27$13.08M$5.66M131.0 %

FAQ

Q

When is Tarsus Pharmaceuticals (NASDAQ:TARS) reporting earnings?

A

Tarsus Pharmaceuticals (TARS) is scheduled to report earnings on February 25, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Tarsus Pharmaceuticals (NASDAQ:TARS)?

A

The Actual EPS was $-0.61, which beat the estimate of $-0.94.

Q

What were Tarsus Pharmaceuticals’s (NASDAQ:TARS) revenues?

A

The Actual Revenue was $48.1M, which beat the estimate of $43.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch